[Implementation of magnesium sulfate into clinical practice to reduce cerebral palsy and neurodisabilities in children born preterm].

The up-dated literature, notably the 2024 Cochrane review, and meta-analysis with individual data, as well as the identified socio-economic benefits, confirms that the administration of magnesium sulfate is recommended in women at risk of imminent pr…

Preview only. Read the full abstract at the source